Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 543616 | NSE Symbol : | ISIN : INE0MKA01014 | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
22-Jul-2025	28-Jul-2025	Quarterly Results	Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/07/2025 inter alia to consider and approve the Unaudited Financial Results (Standalone & Consolidated) of the Company for the quarter ended 30th June 2025 and Any other items with the permission of the chairman. Trident Lifeline Limited has submitted the unaudited financial result (Standalone and consolidated) for the quarter ended June 30,2025 (As Per BSE Announcement Dated on: 28.07.2025)
01-Jul-2025	01-Jul-2025	Conversion	Allotment of 93000 Equity Shares of Rs. 10/- each upon conversion/ exchange of equal number of warrants.
09-Jun-2025	09-Jun-2025	Preferential Issue	Pursuant to the approval of the Shareholders in the Extra ordinary General Meeting held on May 09, 2025, and pursuant to the receipt of the 25% of issue price/application money, we wish to inform you that the Board of Directors of the Company at its meeting held on today i.e. Monday, June 09, 2025 have Considered & Approved Allotment of 9,94,200 Fully Convertible Warrants ('Equity Warrant(s)') each convertible into or exchangeable for, 1 (One) fully paid up equity share of the Company of Face Value of Rs. 10/- (Rupees Ten Only) each at an issue price of Rs. 266/- per warrant (including premium of Rs. 256/- per warrant) on preferential basis to the Promoters/Non-Promoters upon receipt of 25% of issue price from the allottee in accordance with the provisions of SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018
22-Apr-2025	28-Apr-2025	Accounts	Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/04/2025 inter alia to consider and approve Audited Financial Results (Standalone & Consolidated) of the Company for the half year and year ended 31st March 2025 Outcome of Board meeting held on today April 28, 2025 (As Per Bse Announcement Dated on :28.04.2025)
09-Apr-2025	16-Apr-2025	EGM	Preferential Issue of shares & Inter alia, to consider the proposal to raise fund by way of issue of equity shares/convertible warrants Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 16/04/2025 ,inter alia, to consider and approve the proposal to raise fund by way of issue of equity shares/convertible warrants Board of Directors of the company on the meeting held on today dated 16.04.2025 has approved the 1. increase in authorized share capital 2. Approved to create, issue, offer and allot, up to 9,99,000 (Nine Lakh Ninety-Nine Thousand Only) Fully Convertible Warrants. The Board has approved alteration in the Memorandum of Association of the Company subject to the approval of the members. (As per BSE Announcement Dated on 16/04/2025)
26-Mar-2025	26-Mar-2025	Others	Outcome of The Separate Meeting Of Independent Directors Of The Company Held On Wednesday, March 26, 2025.
14-Feb-2025	14-Feb-2025	Subsidiary Company	Trident Lifeline Limited has provided Corporate Guarantee to Subsidiary of the Company.
16-Jan-2025	22-Jan-2025	Quarterly Results	Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/01/2025 inter alia to consider and approve Unaudited Financial Results for quarter ended 31st December 2024 Trident Lifeline Limited has submitted to Exchange the outcome of Board Meeting held on 22.01.2024 Trident Lifeline Limited has submitted the financial result for the Quarter and Nine months ended on December 31, 2024. (As Per BSE Announcement dated on 22.01.2025)
23-Dec-2024	23-Dec-2024	Acquisitions	The Company has proposed to acquire 51% of the Equity Share Capital of TRIDENT MEDIQUIP LIMITED (CIN: U33309GJ2019PLC110421).
26-Nov-2024	26-Nov-2024	Acquisitions	The Company has proposed to subscribe 50.49% of the Equity Share Capital of TLL Parenterals Limited (CIN: U21001GJ2023PLC146963).
15-Oct-2024	19-Oct-2024	Half Yearly Results	Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 19/10/2024 inter alia to consider and approve the Unaudited Standalone and Consolidated financial results of the Company for the half year ended on September 30 2024 Trident Lifeline Limited has submitted to Exchange the outcome of Board Meeting held on 19.10.2024. Trident Lifeline Limited has submitted the financial result for the half year ended on September 30, 2024. (As per BSE Announcement Dated on 19/10/2024) Rectification with respect to the bifurcation of Trade Payable in financial results as per accounting standard is made being intimated by BSE via email dated December 12, 2024. Please note no figures in financial was changed for the half year ended on September 30, 2024. (As Per BSE Announcement Dated on: 20/12/2024)
31-Aug-2024	31-Aug-2024	Change in Other Executives	Appointment of Company Secretary and Compliance Officer of the Company Appointment of Mrs. Nikita Sharma, as Company Secretary and Compliance Officer of the Company
07-Aug-2024	07-Aug-2024	AGM	Outcome of Board Meeting.
13-Jul-2024	17-Jul-2024	Quarterly Results	Trident Lifeline Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/07/2024 inter alia to consider and approve un-audited standalone financial results of the Company for the quarter ended June 30 2024. Trident Lifeline Limited has submitted the outcome of Board Meeting held on 17.07.2024. Trident Lifeline Limited has submitted the Financial Results for the quarter ended 30th June, 2024. (As per BSE Announcement Dated on 17/07/2024)
16-May-2024	16-May-2024	Change in Directors	Trident Lifeline Limited has submitted to the Exchange Outcome of Board Meeting held on 16.05.2024.

1 2

LOGIN HERE

Trident Lifeline Ltd

Board Meeting